Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Brain Neoplasms × Gefitinib × Clear all

Phase

Phase 2 7 Phase 3 3 Phase NA 1 Phase 2/3 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 4 Lung Neoplasms 3 Tongue Neoplasms 1 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thyroid Cancer, Papillary 1 Squamous Cell Carcinoma of Head and Neck 1 Salivary Gland Neoplasms 1 Parathyroid Neoplasms 1 Non-squamous Non-small Cell Lung Cancer 1 Non-Small-Cell Lung 1 NSCLC 1 Gastrointestinal Neoplasms 1 Esthesioneuroblastoma, Olfactory 1 EGFR Mutation Positive Non-small Cell Lung Cancer 1 Carcinoma, Medullary 1 Carcinoma, Hepatocellular 1 Brain Neoplasms 1 Adenocarcinoma, Follicular 1 Adenocarcinoma of Lung 1

Interventions

Radiosurgery 28 Magnetic Resonance Spectroscopy 27 Dexmedetomidine 8 Radiotherapy 7 Radiation 7 Proton Therapy 7 Mental Status and Dementia Tests 7 Magnetic Resonance Imaging 7 Exercise 6 Surgical Procedures, Operative 5 Specimen Handling 5 Saline Solution 5 Blood Specimen Collection 5 Bevacizumab 5 Remifentanil 4 Radiotherapy, Intensity-Modulated 4 Propofol 4 alovudine 3 Transcranial Magnetic Stimulation 3 Temozolomide 3 Resistance Training 3 Methods 3 Mannitol 3 Diffusion Tensor Imaging 3 Cognitive Training 3 gadobutrol 2 gadobenic acid 2 Yoga 2 Vitamin D 2 Ultrasonography 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01363557 2014-05-13

ARPEGE

Assistance Publique - Hôpitaux de Paris

Phase NA Terminated

Brain Neoplasms, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡